As of Feb 12
| 0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 1.75. The median estimate represents a +164.90% increase from the last price of 1.51.
The current consensus among 5 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.